Table 1. IHC analysis of DLBCL cases.
| Marker | % | |
|---|---|---|
| PD-L1 (n = 122) | Tumor positive cases | 15.6 |
| TIL/TAM positive cases | 36.1 | |
| TIM-3 (n = 123) | Tumor positive cases | 39.0 |
| TIL positive cases | 76.2 | |
| PD-1 (n = 120) | Tumor positive cases | 8.3 |
| TIL positive cases | 77.0 | |
| Avg positive TILs/HPF | 31.8 | |
| LAG-3 (n = 120) | Tumor positive cases | 7.5 |
| TIL positive cases | 84.7 | |
| Avg positive TILs/HPF | 46.1 | |
Abbreviations: PD-L1, programmed cell death ligand-1; TIM-3, T cell immunoglobulin and mucin domain-containing protein-3; PD-1, programmed cell death-1; LAG-3, lymphocyte activation gene-3, CD223; TIL, tumor infiltrating lymphocytes; TAM, tumor associated macrophages; HPF, high power field; Avg, average.